IL1B and achalasia-alacrima syndrome: For example, genetic or pharmacological inhibition of IL-1β and its receptor suppressed experimental AAAs induced by the intra-aortic infusion or aortic wall topical painting of porcine pancreatic elastase as well as Kawasaki disease-associated experimental AAAs [12,13,14,15,16,17].